Survey of organ-derived small extracellular vesicles and particles (sEVPs) to identify selective protein markers in mouse serum.

Extracellular vesicles and particles (EVPs) are secreted by organs across the body into different circulatory systems, including the bloodstream, and reflect pathophysiologic conditions of the organ. However, the heterogeneity of EVPs in the blood makes it challenging to determine their organ of origin. We hypothesized that small (s)EVPs (<100 nm in diameter) in the bloodstream carry distinctive protein signatures associated with each originating organ, and we investigated this possibility by studying the proteomes of sEVPs produced by six major organs (brain, liver, lung, heart, kidney, and fat). We found that each organ contained distinctive sEVP proteins: 68 proteins were preferentially found in brain sEVPs, 194 in liver, 39 in lung, 15 in heart, 29 in kidney, and 33 in fat. Furthermore, we isolated sEVPs from blood and validated the presence of sEVP proteins associated with the brain (DPP6, SYT1, DNM1L), liver (FABPL, ARG1, ASGR1/2), lung (SFPTA), heart (CPT1B), kidney (SLC31), and fat (GDN). We further discovered altered levels of these proteins in serum sEVPs obtained from old mice compared to young mice. In sum, we have cataloged sEVP proteins that can serve as potential biomarkers for organ identification in serum and show differential expression with age.

[1]  V. Somoza,et al.  Extracellular Vesicles and Particles Modulate Proton Secretion in a Model of Human Parietal Cells , 2023, ACS omega.

[2]  K. Witwer,et al.  The evolving paradigm of extracellular vesicles in intercellular signaling and delivery of therapeutic RNAs. , 2022, Molecular therapy : the journal of the American Society of Gene Therapy.

[3]  D. Davis,et al.  Heterogeneity in extracellular vesicle secretion by single human macrophages revealed by super‐resolution microscopy , 2022, Journal of extracellular vesicles.

[4]  K. Witwer,et al.  L1CAM‐associated extracellular vesicles: A systematic review of nomenclature, sources, separation, and characterization , 2022, Journal of extracellular biology.

[5]  P. Vader,et al.  ISOLATION METHODS OF LARGE AND SMALL EXTRACELLULAR VESICLES DERIVED FROM CARDIOVASCULAR PROGENITORS: A COMPARATIVE STUDY. , 2021, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[6]  F. Lordick,et al.  Characterization of Total RNA, CD44, FASN, and PTEN mRNAs from Extracellular Vesicles as Biomarkers in Gastric Cancer Patients , 2021, Cancers.

[7]  D. Ahmadvand,et al.  A systematic update to circulating extracellular vesicles proteome; transcriptome and small RNA-ome as glioma diagnostic, prognostic and treatment-response biomarkers. , 2021, Cancer treatment and research communications.

[8]  Qiaojun Fang,et al.  Protein biomarkers in breast cancer-derived extracellular vesicles for use in liquid biopsies. , 2021, American journal of physiology. Cell physiology.

[9]  L. Neri,et al.  The Role of Extracellular Vesicles as Shuttles of RNA and Their Clinical Significance as Biomarkers in Hepatocellular Carcinoma , 2021, Genes.

[10]  E. Aikawa,et al.  Circulating Extracellular Vesicles As Biomarkers and Drug Delivery Vehicles in Cardiovascular Diseases , 2021, Biomolecules.

[11]  F. Gillardon,et al.  Neuronal differentiation of induced pluripotent stem cells from schizophrenia patients in 2D and in 3D cultures reveals increased expression of the Kv4.2 subunit DPP6 that contributes to decreased neuronal activity. , 2020, Stem cells and development.

[12]  G. E. Bruch,et al.  Effects of exercise modalities on BDNF and IL-1β content in circulating total extracellular vesicles and particles obtained from aged rats , 2020, Experimental Gerontology.

[13]  Amber L. Simpson,et al.  Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers , 2020, Cell.

[14]  H. Shao,et al.  Biomarker Organization in Circulating Extracellular Vesicles: New Applications in Detecting Neurodegenerative Diseases , 2020, Advanced biosystems.

[15]  W. Banks,et al.  Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation , 2020, International journal of molecular sciences.

[16]  Y. Karamanos,et al.  Targeting and Crossing the Blood-Brain Barrier with Extracellular Vesicles , 2020, Cells.

[17]  Tom A P Driedonks,et al.  Y-RNA subtype ratios in plasma extracellular vesicles are cell type- specific and are candidate biomarkers for inflammatory diseases , 2020, Journal of extracellular vesicles.

[18]  P. Reddy,et al.  Dynamics of Dynamin-Related Protein 1 in Alzheimer’s Disease and Other Neurodegenerative Diseases , 2019, Cells.

[19]  J. Olcese,et al.  Extraction of Extracellular Vesicles from Whole Tissue. , 2019, Journal of visualized experiments : JoVE.

[20]  Imre Mäger,et al.  Extracellular Vesicle Heterogeneity: Subpopulations, Isolation Techniques, and Diverse Functions in Cancer Progression , 2018, Front. Immunol..

[21]  Patrizia Agostinis,et al.  EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research , 2017, Nature Methods.

[22]  J. Stenvang,et al.  miRNA profiling of circulating EpCAM+ extracellular vesicles: promising biomarkers of colorectal cancer , 2016, Journal of extracellular vesicles.

[23]  R. Pai,et al.  Arginase‐1 is a more sensitive marker of hepatic differentiation than HepPar‐1 and glypican‐3 in fine‐needle aspiration biopsies , 2012, Cancer cytopathology.

[24]  A. Alisi,et al.  Arginase 1: a potential marker of a common pattern of liver steatosis in HCV and NAFLD children. , 2015, Journal of hepatology.